Autism

Autism is a brain development disorder characterized by impaired social interaction and communication, and by restricted and repetitive behavior. These signs all begin before a child is three years old. The autism spectrum disorders (ASD) also include the related conditions Asperger syndrome and PDD-NOS, which have fewer signs and symptoms. Autism has a strong genetic basis, although the genetics of autism are complex and it is unclear whether ASD is explained more by multigene interactions or by rare mutations. In rare cases, autism is strongly associated with agents that cause birth defects. Controversies surround other proposed environmental causes, such as heavy metals, pesticides or childhood vaccines; the vaccine hypotheses are biologically implausible and lack any convincing scientific evidence. The prevalence of ASD is about 6 per 1,000 people, with about four times as many males as females. The number of people known to have autism has increased dramatically since the 1980s, partly due to changes in diagnostic practice; the question of whether actual prevalence has increased is unresolved. Autism affects many parts of the brain; how this occurs is not understood. Parents usually notice signs in the first two years of their child's life. Although early behavioral or cognitive intervention can help children gain self-care, social, and communication skills, there is no known cure. Not many children with autism live independently after reaching adulthood, though some become successful, and an autistic culture has developed, with some seeking a cure and others believing autism should be tolerated as a difference and not treated as a disorder.

Study on infant development

Review and Approval
IRB Flyer: 
Renewal Date: 
2010, April 8

CART ACE II - Project 1: Identifying early signs of autism in high-risk infants

Project summary

The major aim of this study is to identify accurate brain-based markers of autism spectrum disorder (ASD) within the first year of life in infant siblings of children with ASD.  Infant siblings are at an increased risk to develop ASD; studying these infants allows us to characterize the early cognitive and behavioral profiles in infants who later go on to develop autism. Research—including past infant sibling studies (eg. Sigman lab) at UCLA Center for Autism Research and Treatment (CART) —has identified several behavioral, social, and communicative patterns in this population within the first two years of life. This current study builds on this strong foundation and employs a multifaceted approach that incorporates non-invasive MRI, EEG, eye-tracking, and behavioral assessments to closely track these infants’ development in the first year of life. Identification of such predictive brain-based markers of autism early in infancy will allow for earlier diagnosis and intervention, which has shown to improve developmental outcomes in these children. 

You may be eligible for this study if you have an infant under one month old and either:

*Two children with autism; or

*One child with autism and an extended family history of autism

Tarjan Center

Tarjan Center at UCLA

A University Center for Excellence in Disabilities Education, Research and Service

The Tarjan Center is a catalyst for collaboration, innovation, and systems change to advance the self -determination and inclusion of people with disabilities.

We serve as a bridge between the university and persons with disabilities from state, regional and local communities, state and local government agencies and community providers.

Director: 
Olivia Raynor
Provide leadership in education, research and innovative practices that supports all people with disabilities

Open Doors to College

Open the Doors to College

Mission: Open the Doors to College provides information about California’s higher education options for students with intellectual disabilities and autism.

This site provides a directory of programs in California, student stories, resources on services and supports, and tools for program development to assist students, families, and professionals.

Provides information for students and families as they consider their next steps from high school

Early Childhood Partial Hospitalization Program

The Early Childhood Partial Hospitalization Program (ECPHP) at the Resnick Neuropsychiatric Hospital at UCLA is a short-term integrated day treatment program for young children who have been diagnosed with, or may have, autism, developmental disabilities, and behavior disorders:

  • evaluates and treats children in a structured, individualized program
  • develops individual educational, behavioral, and social intervention plans for each child
  • provides family intervention to assist parents in understanding their child’s needs and manage their child’s behavior
  • communicates with school districts and regional centers to facilitate the child’s transition into appropriate educational placements and community services

In this website, there is a summary of the program and its facilities, its suitability and benefits to both children and family, how to register and guidelines on eligibility for health insurance cover.

A short-term integrated day treatment program for young children with autism, developmental disabilities, and behavior disorders

UCLA scientists identify new gene linked to autism risk

Discovery may explain why disorder strikes boys four times more than girls

UCLA scientists have discovered a variant of a gene called CACNA1G that may increase children's risk of developing autism, particularly boys. The journal Molecular Psychiatry publishes the findings in its May 19 advance online edition. Classic autism strikes four times as many boys as girls. When including the entire spectrum of autism disorders, such as the milder Asperger syndrome, boys are 10 times more likely to be diagnosed than girls.

 

The Development of the Siblings of Children with Autism: A Longitudinal Study

Review and Approval
IRB Flyer: 
Renewal Date: 
2009, May 28

World's largest DNA scan for autism uncovers new gene variant for disorder

UCLA scientists, in partnership with 30 research institutions across the country, have identified a new gene variant that is highly common in autistic children. And when researchers scrutinized the activity of the gene, known as CDH10, in the fetal brain, they discovered that it is most active in key regions that support language, speech and interpreting social behavior.